Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) was up 8.9% on Tuesday . The company traded as high as $44.35 and last traded at $44.62. Approximately 1,592,819 shares were traded during mid-day trading, a decline of 71% from the average daily volume of 5,516,613 shares. The stock had previously closed at $40.98.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on TEM shares. Bank of America increased their target price on Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. BTIG Research assumed coverage on shares of Tempus AI in a research report on Monday. They set a "buy" rating and a $60.00 price objective on the stock. Loop Capital reduced their price target on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a report on Tuesday, January 14th. William Blair reissued a "market perform" rating on shares of Tempus AI in a report on Tuesday, February 25th. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a report on Thursday, April 10th. Six analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $61.08.
Read Our Latest Report on TEM
Tempus AI Stock Up 5.4 %
The firm has a 50-day moving average price of $52.83 and a two-hundred day moving average price of $50.44. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.
Insider Activity
In other Tempus AI news, Director Wayne A.I. Frederick sold 3,000 shares of the stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $45.54, for a total transaction of $136,620.00. Following the transaction, the director now directly owns 26,514 shares in the company, valued at $1,207,447.56. This represents a 10.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Nadja West sold 809 shares of the company's stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $51.11, for a total transaction of $41,347.99. Following the completion of the sale, the director now directly owns 37,705 shares of the company's stock, valued at $1,927,102.55. The trade was a 2.10 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,146,249 shares of company stock valued at $301,185,058.
Institutional Investors Weigh In On Tempus AI
A number of institutional investors have recently added to or reduced their stakes in the stock. ARK Investment Management LLC boosted its holdings in shares of Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock valued at $186,343,000 after buying an additional 3,141,487 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its position in shares of Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after purchasing an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. lifted its holdings in shares of Tempus AI by 166.0% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after purchasing an additional 2,021,394 shares during the last quarter. Franklin Resources Inc. lifted its holdings in shares of Tempus AI by 240.5% during the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock valued at $93,251,000 after purchasing an additional 1,950,862 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its stake in Tempus AI by 86,947.2% during the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock worth $55,836,000 after buying an additional 1,651,996 shares during the last quarter. Institutional investors own 24.22% of the company's stock.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
